Omer Faruk Karatas
Omer Faruk Karatas
Verified email at
Cited by
Cited by
Interaction of gold nanoparticles with mitochondria
ÖF Karataş, E Sezgin, Ö Aydın, M Culha
Colloids and Surfaces B: Biointerfaces 71 (2), 315-318, 2009
Identification of miR-139-5p as a saliva biomarker for tongue squamous cell carcinoma: a pilot study
MB Duz, OF Karatas, E Guzel, NF Turgut, M Yilmaz, CJ Creighton, ...
Cellular Oncology 39, 187-193, 2016
Overexpression of miR-145–5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression
M Ozen, OF Karatas, S Gulluoglu, OF Bayrak, S Sevli, E Guzel, ID Ekici, ...
Cancer investigation 33 (6), 251-258, 2015
Designing a gold nanoparticle‐based nanocarrier for microRNA transfection into the prostate and breast cancer cells
A Ekin, OF Karatas, M Culha, M Ozen
The journal of gene medicine 16 (11-12), 331-335, 2014
miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer
OF Karatas, E Guzel, I Suer, ID Ekici, T Caskurlu, CJ Creighton, M Ittmann, ...
PloS one 9 (6), e98675, 2014
Circulating miR-21 and eNOS in subclinical atherosclerosis in patients with hypertension
M Cengiz, S Yavuzer, B Kılıçkıran Avcı, M Yürüyen, H Yavuzer, SA Dikici, ...
Clinical and experimental hypertension 37 (8), 643-649, 2015
MicroRNAs in human tongue squamous cell carcinoma: From pathogenesis to therapeutic implications
OF Karatas, M Oner, A Abay, A Diyapoglu
Oral oncology 67, 124-130, 2017
Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer
E Guzel, OF Karatas, A Semercioz, S Ekici, S Aykan, S Yentur, ...
International Journal of Cancer 136 (4), 875-879, 2015
The role of miRNAs in cancer: from pathogenesis to therapeutic implications
M Seven, OF Karatas, MB Duz, M Ozen
Future oncology 10 (6), 1027-1048, 2014
Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer
E Guzel, OF Karatas, MB Duz, M Solak, M Ittmann, M Ozen
The Prostate 74 (15), 1498-1505, 2014
The altered promoter methylation of oxytocin receptor gene in autism
M Elagoz Yuksel, B Yuceturk, OF Karatas, M Ozen, B Dogangun
Journal of neurogenetics 30 (3-4), 280-284, 2016
Differential expression of hypertension-associated microRNAs in the plasma of patients with white coat hypertension
M Cengiz, OF Karatas, E Koparir, S Yavuzer, C Ali, H Yavuzer, E Kirat, ...
Medicine 94 (13), e693, 2015
Role of miR‐145 in human laryngeal squamous cell carcinoma
OF Karatas, B Yuceturk, I Suer, M Yilmaz, H Cansiz, M Solak, M Ittmann, ...
Head & neck 38 (2), 260-266, 2016
miR‐221 as a pre‐and postoperative plasma biomarker for larynx cancer patients
SS Yilmaz, E Guzel, OF Karatas, M Yilmaz, CJ Creighton, M Ozen
The Laryngoscope 125 (12), E377-E381, 2015
The role of ATP‐binding cassette transporter genes in the progression of prostate cancer
OF Karatas, E Guzel, MB Duz, M Ittmann, M Ozen
The Prostate 76 (5), 434-444, 2016
miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer
OF Karatas, J Wang, L Shao, M Ozen, Y Zhang, CJ Creighton, M Ittmann
Oncotarget 8 (36), 60243, 2017
The role of miR-145 in stem cell characteristics of human laryngeal squamous cell carcinoma Hep-2 cells
OF Karatas, I Suer, B Yuceturk, M Yilmaz, Y Hajiyev, CJ Creighton, ...
Tumor Biology 37, 4183-4192, 2016
RGS12 is a novel tumor-suppressor gene in African American prostate cancer that represses AKT and MNX1 expression
Y Wang, J Wang, L Zhang, OF Karatas, L Shao, Y Zhang, P Castro, ...
Cancer research 77 (16), 4247-4257, 2017
Characterization of stem-like cells directly isolated from freshly resected laryngeal squamous cell carcinoma specimens
I Suer, O Faruk Karatas, B Yuceturk, M Yilmaz, G Guven, B Oz, H Cansiz, ...
Current stem cell research & therapy 9 (4), 347-353, 2014
Novel POC1A mutation in primordial dwarfism reveals new insights for centriole biogenesis
A Koparir, OF Karatas, B Yuceturk, B Yuksel, AO Bayrak, OF Gerdan, ...
Human Molecular Genetics 24 (19), 5378-5387, 2015
The system can't perform the operation now. Try again later.
Articles 1–20